Table 1.
The Demographics of TDF and ETV treated CHB patients
| TDF group | ETV group | Statistics | P | |
|---|---|---|---|---|
|
|
||||
| (n = 33) | (n = 65) | |||
| Age (years) | 35 (26-61) | 39 (20-67) | t = 1.849 | 0.067 |
| Sex (male, %) | 69.7 (23/33) | 81.5 (53/65) | χ2 = 1.763 | 0.184 |
| BMI | 22.63 ± 2.73 | 22.85 ± 2.86 | t = 0.355 | 0.723 |
| Follow-up time (months) | 13.4 (6.2-28.0) | 16 (6.0-27.0) | t = 0.656 | 0.513 |
| The proportion of Alcohol history (%) | 18.2 (6/33) | 24.6 (16/65) | χ2 = 0.520 | 0.471 |
| The proportion of Smoking history (%) | 42.4 (14/33) | 35.4 (23/65) | χ2 = 0.462 | 0.497 |
| Family history of Hepatitis B (%) | 33.3 (11/33) | 30.8 (20/65) | χ2 = 0.067 | 0.796 |
| ALT baseline (U/L) | 194.1 ± 128.5 | 157.6 ± 216.8 | t = 1.043 | 0.300 |
| HBV DNA baseline (Log10 IU/ml) | 6.50 ± 0.69 | 6.15 ± 1.36 | t = 1.701 | 0.092 |
| Rate of Hepatitis B E antigen positive (%) | 60.6 (20/33) | 55.4 (36/65) | χ2 = 0.244 | 0.622 |